Tuesday, November 6, 2007 6:06 am | 
|
Pharmaceutical firm knew of hepatitis C risks from blood product
A pharmaceutical company that manufactured the blood product Christmassin was aware that it had a high risk of infecting users with hepatitis C, it has been learned from the company’s documents.
[MAINICHI]
Related posts
Data on 3,859 fibrinogen victims sat on since ‘01 Asahi: Hepatitis C victims Government hid info on 118 hepatitis victims Ministry vows to track down 280,000 at risk of hepatitis C 11 patients on tainted-blood list already deadJapan News Review
© All rights reserved
None found
While low-cost carriers have since long been successfully operating throughout the U.S., Europe, and southern Asia, Japan has seen very little of the low-price action.
